In this manuscript, we
report the current situation of
tuberculosis globally and in
Brazil, the need for new
strategies toward
tuberculosis control, focusing on new diagnostic
technologies. Critical comments are given on the
state of the
art regarding the evaluation of new
health technologies, degree of scientific evidence needed, evaluation of clinical impact,
cost-
effectiveness of incorporation into the
health system and the
social impact.